candesartan has been researched along with Arteriosclerosis in 4 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan significantly reduced the development of coronary arteriosclerosis (intima/media ratio: 0." | 3.73 | The angiotensin II type 1 receptor blocker candesartan attenuates graft vasculopathy. ( Fukuda, D; Sata, M; Takamoto, S; Yamamoto, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tiefenbacher, CP | 1 |
| Friedrich, S | 1 |
| Bleeke, T | 1 |
| Vahl, C | 1 |
| Chen, X | 1 |
| Niroomand, F | 1 |
| Takai, S | 1 |
| Jin, D | 1 |
| Sakaguchi, M | 1 |
| Muramatsu, M | 1 |
| Ishii, K | 1 |
| Kirimura, K | 1 |
| Sakonjo, H | 1 |
| Miyazaki, M | 1 |
| Chen, J | 1 |
| Li, D | 1 |
| Schaefer, RF | 1 |
| Mehta, JL | 1 |
| Yamamoto, T | 1 |
| Sata, M | 1 |
| Fukuda, D | 1 |
| Takamoto, S | 1 |
4 other studies available for candesartan and Arteriosclerosis
| Article | Year |
|---|---|
ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles.
Topics: Acetylcholine; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibito | 2004 |
Comparative effects of candesartan and amlodipine in a monkey atherosclerotic model.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Aortic | 2004 |
Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Arteriosclerosis; Benzimidazole | 2004 |
The angiotensin II type 1 receptor blocker candesartan attenuates graft vasculopathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arteriosclerosis; Benzimidazoles; Biphenyl Compoun | 2006 |